NewsMV
← News·Markets · OutlookMarkets

PharmAla Biotech Signs $100 Million-Plus Term Sheet to License ALA-002 MDMA Therapeutic to Jupiter Neurosciences

PharmAla Biotech has signed a term sheet granting Jupiter Neurosciences, Inc. (NASDAQ: JUNS) exclusive U.S. licensing rights to ALA-002, its next-generation MDMA therapeutic, in a transaction valued at over $100…

NM
NewsMV Markets Desk
3 min read
23 June 2026Markets desk
Share this dispatch
Categorymarkets

Filed via globenewswire.com

← Back to all dispatchesFront page →
Keep reading

More from the markets desk

Markets · Digital AssetsMarkets

Binance Bitcoin futures volume hits record, outpacing spot trading eight to one

On Binance, the gap between Bitcoin futures and spot trading reached a record divergence, with $BTC futures volume climbing to nearly $58 billion in a single session as the futures-to-spot ratio hit eight times over.…

NM
NewsMV Markets Desk
3 min read
MarketsMarkets

TTWO in focus as Q1 Net Bookings clear guidance and GTA VI locks November 19 date

Grand Theft Auto VI has a confirmed launch: November 19. That date now anchors the full-year setup for Take-Two Interactive Software (NASDAQ: TTWO), which on August 7, 2026 reported fiscal first-quarter Net Bookings of…

NM
NewsMV Markets Desk
3 min read
MarketsMarkets

PepsiCo (PEP) yields over 4% near 52-week lows after North America misses and Citi cuts to Neutral

PepsiCo (PEP) is in focus after Citi downgraded the stock to Neutral from Buy and cut its price target to $145 from $170, a move that came after a Q2 report in which both North American segments missed Street estimates.…

NM
NewsMV Markets Desk
3 min read